Clinical Trial

A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated March 25, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
the safety and tolerability of different dosages of adsorbed acellular pertussis (two-component) diphtheria-tetanus combined vaccine
Trial Details
NCT Number NCT07492303
Lead Sponsor Changchun BCHT Biotechnology Co.
Conditions Pertussis (Whooping Cough), Diphtheria, Tetanus
Enrollment 96 participants
Start Date 2026-04-20
Primary Completion 2026-07-10 (estimated)
Study Completion 2027-08-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-25